Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

"Impressive" HbA1c And Weight Reductions Spur Phase III Plans For Lilly's Dual Incretin Agonist

Oct 04 2018

• By John Davis

Scales

Related Content

Jardiance Is The Star Of Boehringer’s Show, But Micardis Drag Spoils The Party

Aug 02 2018

With Novo Nordisk Dependent On GLP-1s, Even Perceived Price Pressures Can Hurt

Aug 09 2018

Related Companies

Eli Lilly and Company

Novo Nordisk A/S

Boehringer Ingelheim GmbH

Sanofi

Hanmi Pharmaceutical Co., Ltd.

Carmot Therapeutics Inc.

Zealand Pharma A/S

Additional Topics

Clinical Trials Research & Development Market Intelligence Metabolic Disorders BioPharmaceutical

More from Alimentary/Metabolic

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window